Hancock Whitney’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.3M | Sell |
19,692
-660
| -3% | -$669K | 0.32% | 85 |
|
|
2025
Q4 | $21.9M | Sell |
20,352
-868
| -4% | -$830K | 0.39% | 76 |
|
|
2025
Q3 | $16.2M | Sell |
21,220
-13,216
| -38% | -$9.83M | 0.29% | 92 |
|
|
2025
Q2 | $26.8M | Buy |
34,436
+5,523
| +19% | +$4.29M | 0.51% | 55 |
|
|
2025
Q1 | $23.9M | Sell |
28,913
-165
| -0.6% | -$137K | 0.78% | 26 |
|
|
2024
Q4 | $22.4M | Sell |
29,078
-12,613
| -30% | -$10.4M | 0.71% | 29 |
|
|
2024
Q3 | $36.9M | Buy |
41,691
+207
| +0.5% | +$186K | 1.19% | 14 |
|
|
2024
Q2 | $37.6M | Buy |
41,484
+5,982
| +17% | +$4.79M | 1.27% | 14 |
|
|
2024
Q1 | $27.6M | Sell |
35,502
-110
| -0.3% | -$78.3K | 0.95% | 20 |
|
|
2023
Q4 | $20.8M | Buy |
35,612
+6,174
| +21% | +$3.6M | 0.77% | 25 |
|
|
2023
Q3 | $15.8M | Sell |
29,438
-248
| -0.8% | -$128K | 0.65% | 34 |
|
|
2023
Q2 | $13.9M | Buy |
29,686
+12,667
| +74% | +$5.31M | 0.55% | 46 |
|
|
2023
Q1 | $5.84M | Sell |
17,019
-1,379
| -7% | -$465K | 0.23% | 95 |
|
|
2022
Q4 | $6.73M | Sell |
18,398
-142
| -0.8% | -$50.3K | 0.26% | 88 |
|
|
2022
Q3 | $6M | Sell |
18,540
-523
| -3% | -$166K | 0.26% | 86 |
|
|
2022
Q2 | $6.18M | Sell |
19,063
-433
| -2% | -$130K | 0.25% | 85 |
|
|
2022
Q1 | $5.58M | Sell |
19,496
-635
| -3% | -$163K | 0.19% | 103 |
|
|
2021
Q4 | $5.56M | Buy |
20,131
+150
| +0.8% | +$38K | 0.17% | 115 |
|
|
2021
Q3 | $4.62M | Buy |
19,981
+4,495
| +29% | +$1.11M | 0.16% | 110 |
|
|
2021
Q2 | $3.55M | Buy |
15,486
+217
| +1% | +$43.6K | 0.11% | 156 |
|
|
2021
Q1 | $2.85M | Sell |
15,269
-2,336
| -13% | -$457K | 0.1% | 187 |
|
|
2020
Q4 | $2.97M | Sell |
17,605
-257
| -1% | -$38.4K | 0.1% | 182 |
|
|
2020
Q3 | $2.64M | Sell |
17,862
-297
| -2% | -$46K | 0.1% | 167 |
|
|
2020
Q2 | $2.98M | Sell |
18,159
-14,437
| -44% | -$2.22M | 0.11% | 157 |
|
|
2020
Q1 | $4.52M | Buy |
32,596
+5,307
| +19% | +$729K | 0.18% | 138 |
|
|
2019
Q4 | $3.59M | Sell |
27,289
-2,687
| -9% | -$311K | 0.12% | 215 |
|
|
2019
Q3 | $3.35M | Sell |
29,976
-2,072
| -6% | -$231K | 0.11% | 228 |
|
|
2019
Q2 | $3.55M | Buy |
32,048
+233
| +0.7% | +$27.4K | 0.11% | 228 |
|
|
2019
Q1 | $4.13M | Buy |
31,815
+1,293
| +4% | +$157K | 0.13% | 210 |
|
|
2018
Q4 | $3.53M | Buy |
30,522
+4,450
| +17% | +$497K | 0.12% | 225 |
|
|
2018
Q3 | $2.8M | Buy |
+26,072
| New | +$2.61M | 0.08% | 278 |
|
|
2015
Q1 | – | Sell |
-7,403
| Closed | -$511K | – | 519 |
|
|
2014
Q4 | $511K | Sell |
7,403
-326
| -4% | -$22K | 0.02% | 414 |
|
|
2014
Q3 | $501K | Buy |
7,729
+243
| +3% | +$15.4K | 0.02% | 380 |
|
|
2014
Q2 | $465K | Sell |
7,486
-13
| -0.2% | -$776 | 0.02% | 410 |
|
|
2014
Q1 | $441K | Buy |
7,499
+339
| +5% | +$18.9K | 0.02% | 424 |
|
|
2013
Q4 | $365K | Buy |
7,160
+966
| +16% | +$48.4K | 0.02% | 441 |
|
|
2013
Q3 | $312K | Buy |
+6,194
| New | +$324K | 0.01% | 431 |
|
Other funds holding LLY
VCM
VPM
Hancock Whitney's LLY Position: Q1 2026 in Review
Hancock Whitney reduced its Eli Lilly (LLY) stake by 3.2% in Q1 2026, selling an estimated $669K and leaving 19,692 shares worth $18.3M. The position accounts for 0.32% of the portfolio, ranked #85.
Hancock Whitney first reported a position in LLY in Q3 2013 and has held it in 37 quarters since. The position peaked at $37.6M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Hancock Whitney held 19,692 shares of Eli Lilly worth $18.3M as of Q1 2026.
- Hancock Whitney sold 660 Eli Lilly shares in Q1 2026, an estimated $669K.
- Eli Lilly made up 0.32% of Hancock Whitney's portfolio in Q1 2026, its #85 holding.
- Hancock Whitney first reported a position in Eli Lilly in Q3 2013 and has held it in 37 quarters since.
- Hancock Whitney's Eli Lilly position peaked at $37.6M in Q2 2024.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Hancock Whitney's 13F filing for Q1 2026, filed 15 May 2026.